Unlock Your Share of $100B in Non-Dilutive Capital
Join us for this exclusive event to discover how innovative companies can tap into the $100 billion of non-dilutive funding available each year. Gain expert insight from Dr. Eva Garland as she guides you through the complex U.S. funding landscape, covering hundreds of government programs as well as private foundation grants. Plus, hear from Stanley Kim on how WinSanTor secured over $20 million in non-dilutive funding to drive cutting-edge advancements.
Date
June 25, 2025 | 3:30 PM to 7 PM
Location
The Cove @ UCI, 5270 California Ave. Irvine, CA 92617
Agenda
- 3:30 PM – Welcome
Check in and connect with fellow attendees. - 4:00 PM – Presentation by Dr. Eva Garland with Special Guest, Stanley Kim
Gain expert insights from Dr. Eva Garland as she guides you through integrating non-dilutive funding into a comprehensive financing strategy. Plus, hear from Stanley Kim on how WinSanTor secured over $20 million in non-dilutive funding to drive cutting-edge advancements. - 5:00 to 7:00 PM – Cocktail Reception
Enjoy drinks and hors d’oeuvres as you mingle with distinguished guests.
In this Seminar:
- Discover Over $100 Billion in Annual Non-Dilutive Funding Opportunities: Gain a comprehensive understanding of the vast landscape of non-dilutive funding available to innovative companies, including programs from the NIH, ARPA-H, BARDA, and DoD.
- Integrate Non-Dilutive Funding into a Comprehensive Financing Strategy: Learn how non-dilutive sources can complement traditional equity-based funding, resulting in a greater probability of success as well as higher ROI and valuations at exit.
- Gain Practical Insights from a Successful Case Study: Hear from WinSanTor CEO Stanley Kim on how WinSanTor secured over $20 million in non-dilutive funding to advance treatments for peripheral neuropathy, providing a real-world example of leveraging non-dilutive sources to move from pre-clinical to clinical development.
About the speakers:
Dr. Eva Garland, CEO, Eva Garland Consulting
Dr. Eva Garland is the founder and CEO of Eva Garland Consulting (EGC), a nationally recognized leader in securing non-dilutive funding. With offices in Raleigh, North Carolina and Irvine, California, EGC’s team of Ph.D. Scientific Grants Experts and accounting professionals have supported over 3,000 companies in successfully winning over $2 billion in critical non-dilutive funding. EGC’s expert team has helped our clients ranging from early-stage companies to multi-national large pharma obtain grants, from $100K to $100M, that bridge the “valley of death” and advance innovative technologies through the rigorous research & development process.
Stanley Kim, CEO & Founder, WinSanTor
Stanley Kim is a seasoned entrepreneur and the founder of companies across various tech industries, including pharmaceutical/biotechnology, medical device, and software. He is currently CEO and Founder of WinSanTor, a company that has successfully discovered and developed the first disease-modifying therapeutic for peripheral neuropathy. WinSanTor has benefited from over $20 million in non-dilutive funding to advance pre-clinical and clinical development of their leading therapy.
Join University Lab Partners for a Pitch Practice Event before the Seminar from 2 PM – 4 PM.